Neuroma: Clinical Trials

186 trials for Neuroma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

81 completed, 34 recruiting, 33 unknown, 12 terminated. 72 Not applicable, 37 Phase 2, 10 Phase 1, 8 Phase 3, 5 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable72Completed 36, Recruiting 12, Unknown 12, Withdrawn 6, Active not recruiting 3, Terminated 2, Enrolling by invitation 1
Phase 237Completed 17, Terminated 5, Not yet recruiting 4, Recruiting 4, Active not recruiting 3, Unknown 3, Withdrawn 1
Phase 110Completed 4, Not yet recruiting 2, Active not recruiting 1, Recruiting 1, Suspended 1, Terminated 1
Phase 38Terminated 3, Completed 2, Unknown 2, Recruiting 1
Phase 45Withdrawn 3, Completed 1, Unknown 1
Early Phase 14Completed 2, Recruiting 1, Terminated 1

Follow Neuroma: new trials by email Literature Review of Neuroma trials Research Report on Neuroma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of ChatGPT in Vestibular Schwannoma Management
Use of chatGPT for 1 week - Vestibular Schwannoma
Not applicableWithdrawnUniversity of Southern California2027-01-012026-01-13
Selumetinib for NF2-Related Schwannomatosis
Selumetinib - Neurofibromatosis Type 2, NF2
Phase 2Not yet recruitingBeijing Tiantan Hospital202026-12-012026-10-28
Comparative Evaluation of Intraneuroma and Perineuroma Botulinum Toxin Type A Injection Techniques for Chronic Neuroma Pain After Combat-Related Amputation
Botulinum toxin type A injection - Chronic Pain, Neuroma
Not applicableCompletedUkrainian Society of Regional Anesthesia and Pain Therapy1002026-10-012026-10-06
Ultrasound-Guided Platelet-Rich Plasma Versus Local Anesthetic Injection for Chronic Neuroma Pain After Combat-Related Amputation
Platelet-Rich Plasma (PRP) Injections, Local Anesthetic Injection - Neuroma, Phantom Limb Pain After Amputation
Not applicableCompletedUkrainian Society of Regional Anesthesia and Pain Therapy1002026-09-152026-10-07
Luvometinib in Combination With Serplulimab for NF2-Related Tumors
Luvometinib, Serplulimab - NF2-related Schwannomatosis, NF2
Phase 1 / Phase 2Not yet recruitingBeijing Tiantan Hospital302026-07-312026-07-16
Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)
Selumetinib 25mg/m2, Luvometinib, Serplulimab - Neurofibromatosis Type 2, Vestibular Schwannoma
Phase 2Not yet recruitingBeijing Tiantan Hospital2002026-07-182026-07-20
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Panitumumab-IRDye800 - Meningioma, Glioblastoma
Early Phase 1RecruitingEben Rosenthal302026-07-072026-10-16
Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II
Trineumin - Neurofibromatosis Type II, NF2
Phase 1 / Phase 2Not yet recruitingPRG Science & Technology Co., Ltd.252026-07-012026-01-23
Measuring Vestibular Organ Function With Weak Alternating Current Stimulation
Active transcranial electrical vestibular stimulation (Active EVS), Sham transcranial electrical vestibular stimulation (Sham EVS), Control measurement - Vestibular Disorder, Vestibular Schwannoma
Not applicableEnrolling by invitationAalto University302026-06-082026-07-01
Proximal Nerve Cryoablation Versus Perineuroma Cryoablation for Chronic Neuroma Pain After Combat-Related Amputation
Perineuroma Cryoablation, Proximal Nerve Cryoablation - Neuroma, Cryoablation
Not applicableCompletedUkrainian Society of Regional Anesthesia and Pain Therapy502026-05-232026-10-26
Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery
Oliceridine, Sufentanil - PONV, Cerebellopontine Angle Tumor
Not applicableRecruitingXuanwu Hospital, Beijing1742026-03-252026-05-22
Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
Vestibular Schwannoma
Enrolling by invitationEli Lilly and Company1002026-03-022026-11-04
Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis
Auto-captioning Glasses - NF2-related Schwannomatosis
Not applicableCompletedMassachusetts General Hospital182026-02-192026-08-25
Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine
cryoablation, Radiofrequency ablation alone - Pain Management, Quality of Life
Not applicableCompletedUkrainian Society of Regional Anesthesia and Pain Therapy1002026-02-052026-10-19
High-Purity Type I Collagen Nerve Wrapping in Peripheral Nerve Procedures: A Prospective Registry
High-Purity Type I Collagen (HPTC) Nerve Wrap - Peripheral Nerve Injuries, Neuroma of Nerve Repair
Not applicableCompletedAdichunchanagiri Institute of Medical Sciences, B G Nagara402025-12-092026-03-30
Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
Steroids therapy, Placebo - Vestibular Schwannoma, Facial Nerve Paralysis
Phase 3RecruitingBeijing Tiantan Hospital3642025-10-092026-10-26
3D MRE-Based Evaluation of Vestibular Schwannoma Mechanical Properties and Histological Features
Vestibular Schwannoma
RecruitingShengjing Hospital302025-09-252026-10-16
Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap
Tulavi allay Nerve Cap - Neuroma, Neuropathic Pain
Phase 2RecruitingMassachusetts General Hospital202025-09-202026-04-17
Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma
No Intervention: Observational Cohort, Structured home-based vestibular telerehabilitation program, CE-marked clinical rotatory chair - Vestibular Schwannoma, Vestibular Schwannomas
Not applicableRecruitingAlbert Torrents Torrero752025-09-012026-01-23
Results of Nerve Surgery to Treat PostAmputation Pain
Fascicular split, Targeted Muscle Reinnervation - Amputation Neuroma
RecruitingLeiden University Medical Center982025-08-142026-05-26

Showing 20 of 186. Sign in to see all of them.

Narrower conditions

Neuroma, Acoustic (98)  ·  Neurofibromatosis 2 (47)  ·  Neurilemmoma (27)  ·  Meningioma (26)  ·  Brain Neoplasms (15)  ·  Ependymoma (11)  ·  Pain (9)  ·  Glioma (8)  ·  Neurofibromatoses (8)  ·  Hearing Loss (7)  ·  Neurofibromatosis 1 (7)  ·  Vestibular Diseases (7)  ·  Neoplasms (6)  ·  Neuralgia (6)

Broader conditions

Neoplasms by Histologic Type (186)  ·  Neoplasms, Nerve Tissue (186)  ·  Nerve Sheath Neoplasms (184)  ·  Neoplasms (180)  ·  Nervous System Diseases (154)  ·  Neuroectodermal Tumors (141)  ·  Neuroendocrine Tumors (141)  ·  Neoplasms, Germ Cell and Embryonal (139)  ·  Cranial Nerve Diseases (124)  ·  Cranial Nerve Neoplasms (123)  ·  Ear Diseases (122)  ·  Otorhinolaryngologic Neoplasms (122)  ·  Retrocochlear Diseases (121)  ·  Otorhinolaryngologic Diseases (120)

Interventions

Bevacizumab (7)  ·  Radiosurgery (7)  ·  Cochlear Implants (4)  ·  Everolimus (4)  ·  AZD 6244 (3)  ·  Bupivacaine (3)  ·  Gentamicins (3)  ·  Botulinum Toxins, Type A (2)  ·  HDAC-42 (2)  ·  Lapatinib (2)  ·  Lidocaine (2)  ·  Methylprednisolone (2)  ·  Sirolimus (2)  ·  ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine (1)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1)

Sponsors

Massachusetts General Hospital (9)  ·  Massachusetts Eye and Ear Infirmary (6)  ·  Beijing Tiantan Hospital (5)  ·  NYU Langone Health (5)  ·  Northwestern University (5)  ·  University Hospital, Strasbourg, France (5)  ·  Medical University of Vienna (4)  ·  Ukrainian Society of Regional Anesthesia and Pain Therapy (4)  ·  Leiden University Medical Center (3)  ·  National Cancer Institute (NCI) (3)  ·  Seoul National University Hospital (3)  ·  University Hospital Tuebingen (3)  ·  Washington University School of Medicine (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Assistance Publique Hopitaux De Marseille (2)

Countries

United States (88)  ·  France (22)  ·  China (13)  ·  United Kingdom (10)  ·  Netherlands (6)  ·  Austria (5)  ·  Germany (4)  ·  Italy (4)  ·  Norway (4)  ·  Sweden (4)  ·  Ukraine (4)  ·  Denmark (3)  ·  Canada (2)  ·  Czechia (2)  ·  Egypt (2)

Top investigators

Ana-Maria Vranceanu, PhD (3)  ·  Matthias A Karajannis, MD, MS (3)  ·  Scott Plotkin, MD (3)  ·  Aaron Tward, MD (2)  ·  D. Bradley Welling, MD, PhD (2)  ·  Fu Zhao (2)  ·  Matthew L Carlson, MD (2)  ·  Pinan Liu (2)  ·  Theodore Nicolaides, MD (2)  ·  A Mendez Romero (1)  ·  Amy M Moore, MD (1)  ·  Andrii Khomenko, MD (1)

Results publications

PMID 17917842, PMID 19574236, PMID 19645909, PMID 22027076, PMID 10449559, PMID 11587600, PMID 11710496, PMID 11981398, PMID 12925338, PMID 12943357, PMID 14724495, PMID 15354006, PMID 15519876, PMID 15613856, PMID 16046979, PMID 16877612, PMID 16996566, PMID 17438254, PMID 17562049, PMID 18607963, PMID 18758957, PMID 18769654, PMID 18774375, PMID 18946752, PMID 19645932, PMID 20171632, PMID 20513615, PMID 20592851, PMID 20592852, PMID 20802221, PMID 20851113, PMID 21244302, PMID 23573135, PMID 23740337, PMID 24444087, PMID 24904885, PMID 25745609, PMID 26247776, PMID 26276366, PMID 26365993, PMID 26823060, PMID 26933802, PMID 26943915, PMID 26976425, PMID 27025710, PMID 27283169, PMID 28053986, PMID 28385194, PMID 28811848, PMID 28947860

NIH funding

2017 (1), 2018 (1), P30CA006973 (1), P30CA008748 (1), P30CA086862 (1), P30CA138292 (1), P50CA103175 (1), R01DC003196 (1), R01DC012593 (1), R01DC017425 (1), R21CA234760 (1), R44CA261240 (1), U01CA069856 (1)